• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N 端脑利钠肽前体与Ghrelin 和酰化 Ghrelin 在慢性肾脏病透析前的相关性。

N-Terminal Pro-Brain Natriuretic Peptide Correlates with Ghrelin and Acyl-Ghrelin in Pre-Dialysis Chronic Kidney Disease.

机构信息

Department of Nephrology, University of Medicine and Pharmacy "Iuliu Hatieganu", 400012 Cluj-Napoca, Romania.

"Mihai Manasia" Nephrology and Dialysis Clinic, County Emergency Clinical Hospital Cluj, 400347 Cluj-Napoca, Romania.

出版信息

Int J Mol Sci. 2024 May 23;25(11):5696. doi: 10.3390/ijms25115696.

DOI:10.3390/ijms25115696
PMID:38891884
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11171691/
Abstract

Pro-B amino-terminal natriuretic peptide (NT-proBNP) is a diagnostic marker for heart failure (HF), a severe complication of chronic kidney disease (CKD). However, its significance in CKD is not clear, as other factors, such as renal function, may also have an impact. Recent studies have shown that ghrelin treatment is effective in HF in the general population, but the impact of ghrelin on cardiac function in CKD patients is still unknown. Our study aimed to investigate the factors associated with NT-proBNP in pre-dialysis CKD patients and to evaluate the correlation between NT-proBNP and ghrelin and acyl-ghrelin, molecules determined using ELISA methods. In a cross-sectional observational study, we included 80 patients with pre-dialysis CKD, with a mean age of 68 years and 50% men. The median values for NT-proBNP were 351.8 pg/mL, for acyl ghrelin 16.39 pg/mL, and for ghrelin 543.32 pg/mL. NT-proBNP was correlated with ghrelin ( = 0.034, r = 0.24), acyl-ghrelin ( = 0.033, r = -0.24), estimated glomerular filtration rate ( = 0.027, r = -0.25), serum urea ( = 0.006, r = 0.31), and ferritin ( = 0.041, r = 0.28). In multivariate analysis, ghrelin ( = 0.040) and blood urea ( = 0.040) remained significant predictors for NT-proBNP levels. NT-proBNP was a significant predictor for acyl-ghrelin ( = 0.036). In conclusion, in pre-dialysis CKD patients, a high value of NT-proBNP was associated with a high value of total ghrelin and a low value of acyl-ghrelin.

摘要

脑钠肽前体(NT-proBNP)是心力衰竭(HF)的诊断标志物,HF 是慢性肾脏病(CKD)的严重并发症。然而,其在 CKD 中的意义尚不清楚,因为其他因素,如肾功能,也可能有影响。最近的研究表明,ghrelin 治疗对一般人群的 HF 有效,但 ghrelin 对 CKD 患者心脏功能的影响尚不清楚。我们的研究旨在探讨透析前 CKD 患者中与 NT-proBNP 相关的因素,并评估 NT-proBNP 与 ghrelin 和酰基-ghrelin 之间的相关性,这些分子是使用 ELISA 方法确定的。在一项横断面观察性研究中,我们纳入了 80 例透析前 CKD 患者,平均年龄 68 岁,50%为男性。NT-proBNP 的中位数为 351.8pg/ml,酰基-ghrelin 为 16.39pg/ml,ghrelin 为 543.32pg/ml。NT-proBNP 与 ghrelin( = 0.034,r = 0.24)、酰基-ghrelin( = 0.033,r = -0.24)、估算肾小球滤过率( = 0.027,r = -0.25)、血清尿素( = 0.006,r = 0.31)和铁蛋白( = 0.041,r = 0.28)呈正相关。多元分析显示,ghrelin( = 0.040)和血尿素( = 0.040)仍是 NT-proBNP 水平的显著预测因子。NT-proBNP 是酰基-ghrelin( = 0.036)的显著预测因子。结论:在透析前 CKD 患者中,NT-proBNP 水平升高与总 ghrelin 水平升高和酰基-ghrelin 水平降低有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87c1/11171691/c99c1ef55ba2/ijms-25-05696-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87c1/11171691/aedb774792b3/ijms-25-05696-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87c1/11171691/c99c1ef55ba2/ijms-25-05696-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87c1/11171691/aedb774792b3/ijms-25-05696-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87c1/11171691/c99c1ef55ba2/ijms-25-05696-g002.jpg

相似文献

1
N-Terminal Pro-Brain Natriuretic Peptide Correlates with Ghrelin and Acyl-Ghrelin in Pre-Dialysis Chronic Kidney Disease.N 端脑利钠肽前体与Ghrelin 和酰化 Ghrelin 在慢性肾脏病透析前的相关性。
Int J Mol Sci. 2024 May 23;25(11):5696. doi: 10.3390/ijms25115696.
2
High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) Study.高敏肌钙蛋白T和N末端B型利钠肽原(NT-proBNP)与慢性肾脏病患者发生心力衰竭的风险:慢性肾功能不全队列(CRIC)研究
J Am Soc Nephrol. 2015 Apr;26(4):946-56. doi: 10.1681/ASN.2014010108. Epub 2014 Oct 2.
3
Relationship between N-terminal pro-B-type natriuretic peptide plasma levels and renal function evaluated with different formulae in older adult subjects admitted because of dyspnea.因呼吸困难入院的老年患者中,不同公式评估的 N-末端 pro-B 型利钠肽血浆水平与肾功能的关系。
Gerontology. 2012;58(1):50-5. doi: 10.1159/000326243. Epub 2011 Apr 29.
4
B-type natriuretic peptide versus amino terminal pro-B type natriuretic peptide: selecting the optimal heart failure marker in patients with impaired kidney function.B 型利钠肽与氨基末端 pro-B 型利钠肽:在肾功能受损患者中选择最佳心力衰竭标志物。
BMC Nephrol. 2013 May 31;14:117. doi: 10.1186/1471-2369-14-117.
5
Cystatin C-based CKD-EPI equations and N-terminal pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure.基于胱抑素C的慢性肾脏病流行病学合作组(CKD-EPI)方程及N末端B型利钠肽原用于预测急性失代偿性心力衰竭的预后
Clin Cardiol. 2015 Feb;38(2):106-13. doi: 10.1002/clc.22362. Epub 2015 Feb 6.
6
Kidney function crucially affects B-type natriuretic peptide (BNP), N-terminal proBNP and their relationship.肾功能对 B 型利钠肽(BNP)、氨基末端 proBNP 及其相互关系有重要影响。
Eur J Clin Invest. 2014;44(3):303-8. doi: 10.1111/eci.12234. Epub 2014 Jan 20.
7
The interaction between N-terminal pro-brain natriuretic peptide and fluid status in adverse clinical outcomes of late stages of chronic kidney disease.脑钠肽前体 N 端片段与液体状态在慢性肾脏病晚期不良临床结局中的相互作用。
PLoS One. 2018 Aug 22;13(8):e0202733. doi: 10.1371/journal.pone.0202733. eCollection 2018.
8
Clinical Value of Natriuretic Peptides in Predicting Time to Dialysis in Stage 4 and 5 Chronic Kidney Disease Patients.利钠肽在预测4期和5期慢性肾脏病患者开始透析时间方面的临床价值
PLoS One. 2016 Aug 22;11(8):e0159914. doi: 10.1371/journal.pone.0159914. eCollection 2016.
9
Changes in Natriuretic Peptide Levels and Subsequent Kidney Function Decline in SPRINT.SPRINT 中利钠肽水平的变化与随后的肾功能下降。
Am J Kidney Dis. 2024 May;83(5):615-623.e1. doi: 10.1053/j.ajkd.2023.09.018. Epub 2023 Nov 20.
10
The Relationship between Vascular Biomarkers (Serum Endocan and Endothelin-1), NT-proBNP, and Renal Function in Chronic Kidney Disease, IgA Nephropathy: A Cross-Sectional Study.血管生物标志物(血清内皮素和内脂素 1)、NT-proBNP 与慢性肾脏病 IgA 肾病患者肾功能的关系:一项横断面研究。
Int J Mol Sci. 2024 Sep 30;25(19):10552. doi: 10.3390/ijms251910552.

引用本文的文献

1
An Analysis of Post-Adrenalectomy Dynamics in MACS (Mild Autonomous Cortisol Secretion)-Positive Adrenal Tumours: The Biomarkers and Clinical Impact.MACS(轻度自主性皮质醇分泌)阳性肾上腺肿瘤肾上腺切除术后动态分析:生物标志物及临床影响
J Clin Med. 2025 Jul 23;14(15):5217. doi: 10.3390/jcm14155217.
2
An Updated Perspective of the Clinical Features and Parathyroidectomy Impact in Primary Hyperparathyroidism Amid Multiple Endocrine Neoplasia Type 1 (MEN1): Focus on Bone Health.1型多发性内分泌腺瘤病(MEN1)中原发性甲状旁腺功能亢进的临床特征及甲状旁腺切除术影响的最新观点:关注骨骼健康
J Clin Med. 2025 Apr 30;14(9):3113. doi: 10.3390/jcm14093113.

本文引用的文献

1
Diagnostic and Prognostic Value of Aminoterminal Prohormone of Brain Natriuretic Peptide in Heart Failure with Mildly Reduced Ejection Fraction Stratified by the Degree of Renal Dysfunction.根据肾功能不全程度分层的射血分数轻度降低的心力衰竭患者中脑钠肽前体氨基末端在诊断和预后评估中的价值
J Clin Med. 2024 Jan 16;13(2):489. doi: 10.3390/jcm13020489.
2
NT-pro BNP level at dialysis initiation is a useful biomarker for predicting hospitalization for ischemic heart disease.透析开始时 NT-pro BNP 水平可作为预测缺血性心脏病住院的有用生物标志物。
Clin Exp Nephrol. 2024 May;28(5):457-464. doi: 10.1007/s10157-023-02442-x. Epub 2024 Jan 19.
3
Associations between N-Terminal Pro-B-Type Natriuretic Peptide, Body Fluid Imbalance and Quality of Life in Patients Undergoing Hemodialysis: A Cross-Sectional Study.
血液透析患者N端前B型利钠肽、体液失衡与生活质量的相关性:一项横断面研究
J Clin Med. 2023 Nov 28;12(23):7356. doi: 10.3390/jcm12237356.
4
Acyl ghrelin increases cardiac output while preserving right ventricular-pulmonary arterial coupling in heart failure.酰基 ghrelin 可增加心输出量,同时保持心力衰竭时右心室-肺动脉耦联。
ESC Heart Fail. 2024 Feb;11(1):601-605. doi: 10.1002/ehf2.14580. Epub 2023 Nov 29.
5
Changes in Natriuretic Peptide Levels and Subsequent Kidney Function Decline in SPRINT.SPRINT 中利钠肽水平的变化与随后的肾功能下降。
Am J Kidney Dis. 2024 May;83(5):615-623.e1. doi: 10.1053/j.ajkd.2023.09.018. Epub 2023 Nov 20.
6
The Diagnostic Accuracy of N-Terminal Pro-B-Type Natriuretic Peptide and Soluble ST2 for Heart Failure in Chronic Kidney Disease Patients: A Comparative Analysis.N 端脑利钠肽前体和可溶性 ST2 对慢性肾脏病患者心力衰竭的诊断准确性:比较分析。
Med Sci Monit. 2023 Sep 5;29:e940641. doi: 10.12659/MSM.940641.
7
Characteristics of Patients with Heart Failure and Advanced Chronic Kidney Disease (Stages 4-5) Not Undergoing Renal Replacement Therapy (ERCA-IC Study).未接受肾脏替代治疗的心力衰竭合并晚期慢性肾脏病(4-5期)患者的特征(ERCA-IC研究)
J Clin Med. 2023 Mar 17;12(6):2339. doi: 10.3390/jcm12062339.
8
Acyl ghrelin improves cardiac function in heart failure and increases fractional shortening in cardiomyocytes without calcium mobilization.酰基胃泌素可改善心力衰竭患者的心功能,增加心肌细胞的分数缩短,而不引起钙动员。
Eur Heart J. 2023 Jun 9;44(22):2009-2025. doi: 10.1093/eurheartj/ehad100.
9
Chronic Kidney Disease as a Comorbidity in Heart Failure.慢性肾脏病作为心力衰竭的合并症。
Int J Mol Sci. 2023 Feb 3;24(3):2988. doi: 10.3390/ijms24032988.
10
Cardiac Biomarkers and Risk of Atherosclerotic Cardiovascular Disease in Patients with CKD.心脏生物标志物与慢性肾脏病患者动脉粥样硬化性心血管疾病风险
Kidney360. 2022 Mar 2;3(5):859-871. doi: 10.34067/KID.0006222021. eCollection 2022 May 26.